Partner with Us
Join Us in Delivering the First Disease-Modifying Therapy for Brain Calcification Disorders
ZY Therapeutics is advancing ZY-001—a novel, CNS-directed formulation designed to transform outcomes in orphan epilepsies and calcification-driven neurological diseases.
We actively seek mission-aligned partners to accelerate clinical development, expand global reach, and bring this therapy to patients faster.
We Welcome Collaboration With:
- Investors: Early-stage, strategic investors, and family foundations who share our vision to lead in orphan neurotherapeutics.
- Pharma and Biotech Collaborators: Companies seeking innovative orphan-drug pipeline additions in rare CNS disease.
- Patient Advocacy Groups: Foundations and networks that amplify patient voices and research priorities.
- Foundations and Grant Funders: Organizations supporting translational science in rare and pediatric neurology.